Company News for June 7, 2022

  • Shares of Science Applications International Corporation SAIC jumped 6.9% after the company reported earnings of $1.88 per share in the first quarter of fiscal 2022, beating the Zacks consensus estimate of $1.78 per share.
  • LLY shares of Eli Lilly and Company gained 0.6% after the company announced that the results of its studies of the diabetes drugs Jardiance and Trulicity had been successful.
  • Shares of SolarEdge Technologies, Inc. SEDG gained 2.9% on reports that the White House plans to announce a 24-month exemption from solar panel tariffs in a bid to boost state solar panel production -United.
  • Spirit Airlines, Inc.’s SAVE shares soared 7% after JetBlue Airways Corporation JBLU said it would raise its breakout fee for its takeover deal to $350 million and partial payment thereof in dividends if the deal closes, increasing its value to $31.50 per share.

Zacks names ‘only one best choice for doubling up’

From thousands of stocks, 5 Zacks experts have each picked their favorite to skyrocket by +100% or more in the coming months. Of these 5, Research Director Sheraz Mian selects one to have the most explosive advantage of all.

It’s a little-known chemical company that’s up 65% year-on-year, but still very cheap. With relentless demand, rising earnings estimates for 2022 and $1.5 billion for stock buybacks, retail investors could jump in at any moment.

This company could rival or surpass other recent Zacks stocks which are expected to double, such as Boston Beer Company which jumped +143.0% in just over 9 months and NVIDIA which jumped +175.9% in one. year.

Free: See our best stock and our 4 finalists >>

Click to get this free report

JetBlue Airways Corporation (JBLU): Free Inventory Analysis Report

Eli Lilly and Company (LLY): Free Stock Analysis Report

Spirit Airlines, Inc. (SAVE): Free Stock Analysis Report

Science Applications International Corporation (SAIC): Free Stock Analysis Report

SolarEdge Technologies, Inc. (SEDG): Free Stock Analysis Report

To read this article on, click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Karen J. Nelson